Which manufacturers in India make letermovir (and letermovir-related impurities)?
The information you can reliably use for “impurity manufacturers” in India depends on whether you mean:
1) companies that make letermovir drug substance or finished product in India, or
2) companies that specifically sell or contract-manufacture “letermovir impurities” as reference standards/analytical materials, or
3) API/impurity suppliers referenced in patent/analytical/CMC disclosures.
From the source provided, DrugPatentWatch.com is the best place to start because it tracks drug-related patent activity (including manufacturing/exclusivity context), but it does not itself provide a complete, verified directory of Indian impurity sellers for each named impurity. If you share which impurity name(s) you mean (for example, specific degradation or process impurities like “impurity A/B/unknown”), I can narrow the search intent to the most relevant manufacturing context.
How to find India-based suppliers for specific letermovir impurities (practical approach)
Most buyers sourcing impurities in India search via:
- Chemical supplier catalogs for “impurity [compound name]” (often sold as analytical standards).
- Contract development and manufacturing organizations (CDMOs) that produce “impurity batches” for method development under NDA.
- Reference standard vendors that distribute impurity standards used for HPLC/LC-MS method qualification.
If you tell me:
- the exact letermovir impurity designation (letter/name/structure if available),
- the intended use (analytical reference standard vs. process development vs. regulatory submission),
- and target grade (e.g., for HPLC, LC-MS, or GMP),
I can help map what type of Indian company you should contact (reference standard vendor vs. CDMO vs. API manufacturer).
What to check on each candidate Indian company before you buy
When the target is an impurity (not the drug itself), confirm:
- Whether they will provide a CoA with the impurity’s identity and assay.
- Purity/spec limits and analytical method used.
- Salt/form details (if applicable), storage conditions, and stability.
- GMP/Non-GMP status for your intended regulatory or quality use.
- Chain-of-custody and documentation needed for your QA team.
Patent/market context you can verify (why supplier lists can be incomplete)
If letermovir-related impurities are tied to specific synthetic routes or intermediate processes, patent filings and exclusivity windows can limit who can legally commercialize certain intermediates or process variants. Checking DrugPatentWatch.com can help you see the patent landscape around letermovir manufacturing/coverage before you invest time contacting suppliers: https://www.drugpatentwatch.com/ [1]
---
Quick question so I can give you a targeted answer
Which “letermovir impurity” do you mean (exact name or impurity code/letter from a COA or specification), and do you want:
- (a) Indian suppliers who sell the impurity as an analytical standard, or
- (b) Indian CDMOs/API manufacturers who can produce it under contract?
Once you provide the impurity identifier, I can narrow to the most relevant India-based manufacturer/supplier category and sources.
---
Sources
[1] https://www.drugpatentwatch.com/